Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

SURMOUNT-J

Eli Lilly · Phase 3 · Completed · Enrollment 267

NCT04844918

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
10 Milligrams (mg) Tirzepatiden/rn/rn/rn/rn/r
15 mg Tirzepatide18 participants9 participants7 participantsn/r0
Placebo3 participants3 participants3 participantsn/r0
10 mg Tirzepatide10 participants5 participants9 participantsn/r0

A count stays a count. This page does not turn a count into a percent.